A $450 Million Partnership Investing in Technology and Healthcare

Each new fund brings great opportunity to the world around us. Polaris Partners VII marks our ongoing commitment to advancing novel ideas and building breakthrough companies. True partnerships matter - and we are thrilled to embark on this next journey alongside extraordinary leaders who seek to make the world a better place. We wish to thank our companies, investors, and colleagues for placing their trust in us year after year, fund after fund. We're proud to be your partners and know that the best is yet to come.
"The Polaris team and I have cultivated a special relationship which transcends traditional partnerships.�I count several of the partners among my closest friends, with a third of their biotech team having completed their PhD or postdoc in my lab before joining the firm. Together we have created nearly 20 companies. The hallmarks of a Polaris company are big ideas backed by great scientists, terrific business people, and powerful intellectual property. They go out of their way to treat everyone fairly - founders, employees, and other investors. It's been a privilege to work with them and I believe we have, and will continue to, change the world."

~ Dr. Robert Langer
MIT Professor and Polaris Company Co-Founder

"With the initial investment from Polaris, they demonstrated massive energy out of the gate by not only leading our oversubscribed funding round, but also immediately rolling up their sleeves and connecting us with customers, partners and talent from their network. Having leveraged their experience as operators to help scale many transformative SaaS companies, Polaris gets it – and they have our back – which means everything to companies like ours that are growing exponentially."

~ Dave Elkington
Chairman, CEO and Co-Founder, InsideSales.com
"I joined my first Polaris company over a decade ago and am now a multiple, repeat entrepreneur in the Polaris portfolio, both as a CEO and as a Board member. I've worked with many people at Polaris, and I find myself repeatedly drawn back to this team. There's a consistent combination of creativity, vision, integrity, and commitment to create important companies that really break boundaries. It's never easy to do that, but shared experiences go a long way in this business and we certainly count that factor heavily in our success. I know we can overcome challenges together."

~ Katrine Bosley
Polaris Repeat Entrepreneur, CEO, Editas Medicine

"In our early days, Polaris was one of the first investors to recognize the transformative potential that our freemium product approach represented. They were integral to our go-to-market strategy by helping us build out our executive bench and Board while applying their own operating chops to our efforts. Today, our standing as the largest SaaS network in the world and a public company with over a billion dollars in value was made possible in no small part by the strong foundation we established together as partners."

~ Michael Simon
CEO, LogMeIn (Nasdaq: LOGM)
"When Polaris invested in Cardlytics we were two people with a Powerpoint deck and a dream. We were trying to build a massive network that brought together banks and advertisers in an unprecedented fashion. Naturally, executing on this vision required significant time and resources. Polaris has been a patient and helpful investor. Beyond capital, they have also provided introductions and strategic counsel, helping to make the dream into a reality."

~ Lynne Laube
President and Co-Founder, Cardlytics

"Opportunities to move scientific discoveries from the labs into the hands of patients have never been greater. As a card-carrying member of the Polaris friends and entrepreneurial family, I know first-hand that Polaris's steadfast commitment to advancing biotechnology platforms has created hundreds of companies that have, in turn, helped millions of patients live better lives. It's a benevolent circle that pays dividends far beyond those we can measure."

~ Phillip Sharp
Nobel Laureate, MIT Professor and Co-Founder of Alnylam Pharmaceuticals (Nasdaq: ALNY)
Polaris Partners invests in exceptional technology and healthcare companies across all stages of their lifecycles.�With offices in Boston, San Francisco, and Dublin, we partner globally with an unparalleled network of repeat entrepreneurs, top scientists and emerging innovators who are making a significant impact in their fields and improving the way in which we live and work.